Metabolic syndrome for the prognosis of postoperative complications after open pancreatic surgery in Chinese adult: a propensity score matching study
Data files
May 12, 2022 version files 54.76 KB
-
Data_Information.xlsx
54.01 KB
-
README_file.txt
753 B
Feb 28, 2023 version files 71.70 KB
-
Data_Information.xlsx
70.24 KB
-
README.md
1.45 KB
Abstract
Background: To investigate the relationship between metabolic syndrome (MS) and postoperative complications in Chinese adults after open pancreatic surgery.
Methods: Relevant data were retrieved from the Medicalsystem® database of Changhai hospital (MDCH). All patients who underwent pancreatectomy from January 2017 to May 2019 were included, and relevant data were collected and analyzed. A propensity score matching (PSM) and a multivariate generalized estimating equation were used to investigate the association between MS and composite compositions during hospitalization. Cox regression model was employed for survival analysis.
Results: 1481 patients were finally eligible for this analysis. According to diagnostic criteria of Chinese MS, 235 patients were defined as MS, and the other 1246 patients were controls. After PSM, no association was found between MS and postoperative composite complications (OR: 0.958, 95%CI: 0.715-1.282, P=0.958). But MS was associated with postoperative acute kidney injury (OR: 1.730, 95%CI: 1.050-2.849, P=0.031). Postoperative AKI was associated with mortality in 30 days and 90 days after surgery (P<0.001).
Conclusions: MS is not an independent risk factor correlated with postoperative composite complications after open pancreatic surgery. But MS is an independent risk factor for postoperative AKI of pancreatic surgery in Chinese population, and AKI is associated with survival after surgery.
Methods
A clinical electronic medical record system was used to retrieve medical records of all patients undergoing elective pancreatectomy. The selected patients were identified with the key words "pancreas" and "anesthesia". This study met the ethical standards stipulated by the National Health Commission of the People's Republic of China (Act 11, 2016) and was approved by the ETHICS Committee.
Usage notes
IBM SPSS® Statistics v21 (IBM Corporation, NY, USA)
RStudio (version 4.1.3).